Clincosm LogoSign in Get a demo

anaplastic thyroid cancer

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anaplastic Thyroid Cancer Trial in Leiden (dabrafenib/trametinib)

Recruiting
  • Anaplastic Thyroid Cancer
  • Leiden, Zuid-Holland, Netherlands
    Ellen Kapiteijn
Oct 5, 2023

Trends in Anaplastic Thyroid Cancer Patients' Clinical Study

Not yet recruiting
  • Anaplastic Thyroid Cancer
    • (no location specified)
    Apr 6, 2023

    Surgical Management of Advanced Thyroid Cancer

    Recruiting
    • Thyroid Carcinoma
    • +6 more
    • Thyroidectomy with or without lymphadenectomy or multivisceral resection
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Mar 31, 2023

    Anaplastic Thyroid Cancer Trial in Japan (Lenvatinib, Nivolumab)

    Recruiting
    • Anaplastic Thyroid Cancer
    • Nagoya, Aichi, Japan
    • +9 more
    Jan 13, 2023

    Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

    Active, not recruiting
    • Thyroid Cancer
    • +2 more
    • Stanford, California
      Stanford University
    Nov 8, 2022

    Melanoma, Non-small Sell Lung Cancer (NSCLC), Triple Negative Breast Cancer Trial in Worldwide (PDR001)

    Completed
    Has Results
    • Melanoma
    • +4 more
    • PDR001
    • Baltimore, Maryland
    • +40 more
    Aug 2, 2022

    Anaplastic Thyroid Cancer, Thyroid Cancer, BRAF Gene Mutation Trial in United States (Dabrafenib, Trametinib)

    Recruiting
    • Anaplastic Thyroid Cancer
    • +3 more
    • Basking Ridge, New Jersey
    • +6 more
    Jul 1, 2022

    Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,

    Recruiting
    • Metastatic Solid Tumor
    • +6 more
    • Surufatinib and Tislelizumab _ Part 1
    • Surufatinib and Tislelizumab _ Part 2
    • Tucson, Arizona
    • +17 more
    Apr 1, 2022

    Anaplastic Thyroid Cancer Trial in United States (Trametinib, Paclitaxel)

    Active, not recruiting
    • Anaplastic Thyroid Cancer
    • Basking Ridge, New Jersey
    • +6 more
    Mar 10, 2022

    Anaplastic Thyroid Cancer, Relapsed/Refractory Poorly Differentiated Thyroid Cancer Trial in New York, Houston (AIC100 CAR T

    Recruiting
    • Anaplastic Thyroid Cancer
    • Relapsed/Refractory Poorly Differentiated Thyroid Cancer
    • AIC100 CAR T Cells
    • New York, New York
      Weill Cornell Medical College
    Feb 14, 2022

    Anaplastic Thyroid Cancer, Thyroid Cancer Trial in Newport Beach, Boston, Ann Arbor (MLN0128)

    Active, not recruiting
    • Anaplastic Thyroid Cancer
    • Thyroid Cancer
    • Newport Beach, California
    • +2 more
    Feb 18, 2022

    Neuroendocrine Tumor, Anaplastic Thyroid Cancer, Adenocarcinoma Trial in Spain (Cabozantinib 40 mg)

    Recruiting
    • Neuroendocrine Tumor
    • +4 more
    • Cabozantinib 40 mg
    • Badalona, Barcelona, Spain
    • +14 more
    Feb 15, 2022

    Anaplastic Thyroid Cancer Trial in Dallas (Pembrolizumab)

    Completed
    Has Results
    • Anaplastic Thyroid Cancer
    • Dallas, Texas
      UT Southwestern Medical Center
    Feb 8, 2022

    Anaplastic Thyroid Cancer, ATC Trial in Shanghai (HLX208)

    Recruiting
    • Anaplastic Thyroid Cancer
    • ATC
    • Shanghai, China
      Fudan University Affiliated Oncology Hospital
    Dec 30, 2021

    Anaplastic Thyroid Cancer, Recurrent Thyroid Cancer Trial in United States (efatutazone, paclitaxel)

    Active, not recruiting
    Has Results
    • Anaplastic Thyroid Cancer
    • Recurrent Thyroid Cancer
    • Anchorage, Alaska
    • +252 more
    Aug 16, 2021

    Anaplastic Thyroid Cancer Trial in Ireland, United Kingdom (Tissue, blood and clinical data collection)

    Recruiting
    • Anaplastic Thyroid Cancer
    • Tissue, blood and clinical data collection
    • Dublin, Ireland
    • +14 more
    Dec 30, 2020

    Anaplastic Thyroid Cancer Trial in Beijing (HX008)

    Not yet recruiting
    • Anaplastic Thyroid Cancer
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Oct 2, 2020

    Anaplastic Thyroid Cancer Trial in United States (CS-7017, Paclitaxel)

    Terminated
    Has Results
    • Anaplastic Thyroid Cancer
    • Aurora, Colorado
    • +9 more
    Aug 31, 2020

    Anaplastic Thyroid Cancer Trial in Japan (Lenvatinib)

    Completed
    • Anaplastic Thyroid Cancer
    • Nagoya-city, Aichi-prefecture, Japan
    • +22 more
    Jun 16, 2020

    Anaplastic Thyroid Cancer, Recurrent Thyroid Cancer Trial in Cleveland (sorafenib tosylate)

    Terminated
    Has Results
    • Anaplastic Thyroid Cancer
    • Recurrent Thyroid Cancer
    • sorafenib tosylate
    • Cleveland, Ohio
      Case Western Reserve University
    Dec 20, 2017

    Solid Tumor, Anaplastic Thyroid Cancer Trial run by the NCI (Crolibulin, Cisplatin)

    Completed
    Has Results
    • Solid Tumor
    • Anaplastic Thyroid Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Feb 27, 2017

    Anaplastic Thyroid Cancer Trial in Worldwide (CA4P, paclitaxel, carboplatin)

    Terminated
    Has Results
    • Anaplastic Thyroid Cancer
    • Los Angeles, California
    • +40 more
    May 12, 2014

    Anaplastic Thyroid Cancer Trial (Fosbretabulin + paclitaxel + carboplatin, Placebo + paclitaxel + carboplatin)

    Withdrawn
    • Anaplastic Thyroid Cancer
    • Fosbretabulin + paclitaxel + carboplatin
    • Placebo + paclitaxel + carboplatin
    • (no location specified)
    Apr 30, 2014

    Anaplastic Thyroid Cancer, Insular Thyroid Cancer, Recurrent Thyroid Cancer Trial in Columbus (drug, other, radiation,

    Terminated
    • Anaplastic Thyroid Cancer
    • +6 more
    • sorafenib tosylate
    • +5 more
    • Columbus, Ohio
      Ohio State University Medical Center
    Jan 15, 2014

    Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

    Completed
    • Advanced Adult Primary Liver Cancer
    • +126 more
    • recombinant interleukin-12
    • ABI-007/carboplatin/trastuzumab
    • Columbus, Ohio
      Ohio State University Medical Center
    Feb 27, 2013